Phase Ii Randomized Trial Of Neoadjuvant Trastuzumab And Pertuzumab With Either Palbociclib Plus Letrozole Or Paclitaxel For Postmenopausal Women With Estrogen Receptor-Positive/Her2-Positive Breast Cancer - The Touch Trial
CANCER RESEARCH（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined